SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-227356
Filing Date
2009-11-06
Accepted
2009-11-06 15:06:14
Documents
5
Period of Report
2009-11-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 23499
2 INDENTURE dex991.htm EX-99.1 574252
3 PURCHASE AND SALE AGREEMENT dex992.htm EX-99.2 299909
4 PLEDGE AND SECURITY AGREEMENT dex993.htm EX-99.3 126047
5 BILL OF SALE dex994.htm EX-99.4 24548
  Complete submission text file 0001193125-09-227356.txt   1049953
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 091164458
SIC: 2836 Biological Products, (No Diagnostic Substances)